Suppr超能文献

A2A 腺苷受体拮抗剂结合模式的计算研究。

Computational studies of the binding modes of A 2A adenosine receptor antagonists.

作者信息

Ye Y, Wei J, Dai X, Gao Q

机构信息

School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.

出版信息

Amino Acids. 2008 Aug;35(2):389-96. doi: 10.1007/s00726-007-0604-2. Epub 2007 Nov 5.

Abstract

A molecular docking study was performed on several structurally diverse A(2A) AR antagonists, including xanthines, and non-xanthine type antagonists to investigate their binding modes with A(2A) adenosine receptor (AR), one of the four subtypes of AR, which is currently of great interest as a target for therapeutic intervention, in particular for Parkinson's disease. The high-affinity binding site was found to be a hydrophobic pocket with the involvement of hydrogen bonding interactions as well as pi-pi stacking interactions with the ligands. The detailed binding modes for both xanthine and non-xanthine type A(2A) antagonists were compared and the essential features were extracted and converted to database searchable queries for virtual screening study of novel A(2A) AR antagonists. Findings from this study are helpful for elucidating the binding pattern of A(2A) AR antagonists and for the design of novel active ligands.

摘要

对几种结构各异的A(2A) 腺苷受体(AR)拮抗剂进行了分子对接研究,这些拮抗剂包括黄嘌呤类和非黄嘌呤类拮抗剂,以研究它们与A(2A) 腺苷受体(AR)的结合模式。A(2A) 腺苷受体是AR的四种亚型之一,目前作为治疗干预的靶点,尤其是帕金森病的治疗靶点备受关注。研究发现,高亲和力结合位点是一个疏水口袋,涉及氢键相互作用以及与配体的π-π堆积相互作用。比较了黄嘌呤类和非黄嘌呤类A(2A) 拮抗剂的详细结合模式,提取了关键特征并将其转化为可用于数据库搜索的查询,以进行新型A(2A) 腺苷受体拮抗剂的虚拟筛选研究。本研究结果有助于阐明A(2A) 腺苷受体拮抗剂的结合模式,并有助于设计新型活性配体。

相似文献

1
Computational studies of the binding modes of A 2A adenosine receptor antagonists.
Amino Acids. 2008 Aug;35(2):389-96. doi: 10.1007/s00726-007-0604-2. Epub 2007 Nov 5.
3
The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Bioorg Chem. 2013 Aug;49:49-58. doi: 10.1016/j.bioorg.2013.06.006. Epub 2013 Jul 4.
5
Pharmacophore modeling of human adenosine receptor A(₂A) antagonists.
J Mol Model. 2010 Dec;16(12):1867-76. doi: 10.1007/s00894-010-0690-z. Epub 2010 Mar 12.
6
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.
Structure. 2011 Sep 7;19(9):1283-93. doi: 10.1016/j.str.2011.06.014.
7
A New Series of 1,3-Dimethylxanthine Based Adenosine A Receptor Antagonists as a Non-Dopaminergic Treatment of Parkinson's Disease.
Curr Drug Discov Technol. 2021;18(5):e26082020185360. doi: 10.2174/1570163817666200827112252.

引用本文的文献

1
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.
Curr Neuropharmacol. 2018;16(6):786-848. doi: 10.2174/1570159X16666180308161642.

本文引用的文献

1
Cleavage mechanism of the H5N1 hemagglutinin by trypsin and furin.
Amino Acids. 2008 Aug;35(2):375-82. doi: 10.1007/s00726-007-0611-3. Epub 2008 Jan 31.
2
Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. doi: 10.1016/j.bbrc.2007.08.025. Epub 2007 Aug 13.
3
Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP.
Biochem Biophys Res Commun. 2007 Jul 27;359(2):323-9. doi: 10.1016/j.bbrc.2007.05.101. Epub 2007 May 24.
4
Computational studies of the binding mechanism of calmodulin with chrysin.
Biochem Biophys Res Commun. 2007 Jul 13;358(4):1102-7. doi: 10.1016/j.bbrc.2007.05.053. Epub 2007 May 22.
5
Agaritine and its derivatives are potential inhibitors against HIV proteases.
Med Chem. 2007 May;3(3):221-6. doi: 10.2174/157340607780620644.
6
3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.
J Chem Inf Model. 2007 Mar-Apr;47(2):613-25. doi: 10.1021/ci600410m. Epub 2007 Mar 2.
7
3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design.
Biochem Biophys Res Commun. 2007 Apr 6;355(2):513-9. doi: 10.1016/j.bbrc.2007.01.185. Epub 2007 Feb 8.
8
Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
Biochem Biophys Res Commun. 2007 Mar 16;354(3):634-40. doi: 10.1016/j.bbrc.2006.12.235. Epub 2007 Jan 19.
9
Inhibitor design for SARS coronavirus main protease based on "distorted key theory".
Med Chem. 2007 Jan;3(1):1-6. doi: 10.2174/157340607779317616.
10
Progress in computational approach to drug development against SARS.
Curr Med Chem. 2006;13(27):3263-70. doi: 10.2174/092986706778773077.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验